Transmission Potential and Design of Adequate Control Measures for Marburg Hemorrhagic Fever

被引:25
作者
Ajelli, Marco [1 ]
Merler, Stefano [1 ]
机构
[1] Bruno Kessler Fdn, Trento, Italy
来源
PLOS ONE | 2012年 / 7卷 / 12期
关键词
VIRUS-DISEASE; NONHUMAN-PRIMATES; INFLUENZA; OUTBREAK; EBOLA; STRATEGIES; EPIDEMIC; ANGOLA;
D O I
10.1371/journal.pone.0050948
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Marburg hemorrhagic fever is rare yet among the most severe diseases affecting humans, with case fatality ratio even higher than 80%. By analyzing the largest documented Marburg hemorrhagic fever epidemic, which occurred in Angola in 2005 and caused 329 deaths, and data on viral load over time in non-human primates, we make an assessment of transmissibility and severity of the disease. We also give insight into the control of new Marburg hemorrhagic fever epidemics to inform appropriate health responses. We estimated the distribution of the generation time to have mean 9 days (95%CI: 8.2-10 days) and standard deviation 5.4 days (95%CI: 3.9-8.6 days), and the basic reproduction number to be R-0 = 1.59 (95%CI: 1.53-1.66). Model simulations suggest that a timely isolation of cases, starting no later than 2-3 days after symptoms onset, is sufficient to contain an outbreak. Our analysis reveals that Marburg hemorrhagic fever is characterized by a relatively small reproduction number and by a relatively long generation time. Such factors, along with the extremely high severity and fatality, support the rare occurrence of large epidemics in human populations. Our results also support the effectiveness of social distancing measures - case isolation in particular - to contain or at least to mitigate an emerging outbreak. This work represents an advance in the knowledge required to manage a potential Marburg hemorrhagic fever epidemic.
引用
收藏
页数:8
相关论文
共 47 条
[1]   Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy [J].
Ajelli, M. ;
Merler, S. ;
Pugliese, A. ;
Rizzo, C. .
EPIDEMIOLOGY AND INFECTION, 2011, 139 (01) :68-79
[2]  
ANDERSON R M, 1991
[3]  
[Anonymous], 2012, INT DAT BAS
[4]   Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation [J].
Baguelin, Marc ;
Van Hoek, Albert Jan ;
Jit, Mark ;
Flasche, Stefan ;
White, Peter J. ;
Edmunds, W. John .
VACCINE, 2010, 28 (12) :2370-2384
[5]   Marburg hemorrhagic fever associated with multiple genetic lineages of virus [J].
Bausch, Daniel G. ;
Nichol, Stuart T. ;
Muyembe-Tamfum, Jean Jacques ;
Borchert, Matthias ;
Rollin, Pierre E. ;
Sleurs, Hilde ;
Campbell, Patricia ;
Tshioko, Florimund K. ;
Roth, Catherine ;
Colebunders, Robert ;
Pirard, Patricia ;
Mardel, Simon ;
Olinda, Loku A. ;
Zeller, Herve ;
Tshomba, Antoine ;
Kulidri, Amayo ;
Libande, Modeste L. ;
Mulangu, Sabue ;
Formenty, Pierre ;
Grein, Thomas ;
Leirs, Herwig ;
Braack, Leo ;
Ksiazek, Tom ;
Zaki, Sherif ;
Bowen, Michael D. ;
Smit, Sheilagh B. ;
Leman, Patricia A. ;
Burt, Felicity J. ;
Kemp, Alan ;
Swanepoel, Robert .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :909-919
[6]   Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo [J].
Bausch, DG ;
Borchert, M ;
Grein, T ;
Roth, C ;
Swanepoel, R ;
Libande, ML ;
Talarmin, A ;
Bertherat, E ;
Muyembe-Tamfum, JJ ;
Tugume, B ;
Colebunders, R ;
Kondé, KM ;
Pirard, P ;
Olinda, LL ;
Rodier, GR ;
Campbell, P ;
Tomori, O ;
Ksiazek, TG ;
Rollin, PE .
EMERGING INFECTIOUS DISEASES, 2003, 9 (12) :1531-1537
[7]  
Bettencourt L.M.A., 2009, Mathematical and Statistical Estimation Approaches in Epidemiology, P143, DOI [10.1007/978-90-481-2313-17, DOI 10.1007/978-90-481-2313-17]
[8]  
Boëlle PY, 2009, EUROSURVEILLANCE, V14, P10
[9]   A cluster of Marburg virus disease involving an infant [J].
Borchert, M ;
Muyembe-Tamfum, JJ ;
Colebunders, R ;
Libande, M ;
Sabue, M ;
Van der Stuyft, P .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2002, 7 (10) :902-906
[10]   Hemorrhagic fever viruses as biological weapons - Medical and public health management [J].
Borio, L ;
Inglesby, T ;
Peters, CJ ;
Schmaljohn, AL ;
Hughes, JM ;
Jahrling, PB ;
Ksiazek, T ;
Johnson, KM ;
Meyerhoff, A ;
O'Toole, T ;
Ascher, MS ;
Bartlett, J ;
Breman, JG ;
Eitzen, EM ;
Hamburg, M ;
Hauer, J ;
Henderson, A ;
Johnson, RT ;
Kwik, G ;
Layton, M ;
Lillibridge, S ;
Nabel, GJ ;
Osterholm, MT ;
Perl, TM ;
Russell, P ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18) :2391-2405